Wealthfront Advisers’s Celgene Corp CELG Stock Holding History

Wealthfront Advisers’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-37,311	Closed	-$3.71M	–	506
2019 Q3	$3.71M	Buy	37,311 +3,972	+12%	+$377K	0.03%	92
2019 Q2	$3.08M	Buy	33,339 +7,272	+28%	+$691K	0.03%	103
2019 Q1	$2.46M	Buy	26,067 +10,817	+71%	+$946K	0.02%	122
2018 Q4	$977K	Buy	+15,250	New	+$1.13M	0.01%	247

Other funds holding CELG

HCM

Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Wealthfront Advisers's CELG Position: Q4 2019 in Review

Wealthfront Advisers sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 37,311 shares — an estimated $3.71M sold.

Wealthfront Advisers first reported a position in CELG in Q4 2018 and held it in 4 quarters. The position peaked at $3.71M in Q3 2019. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Wealthfront Advisers reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Wealthfront Advisers sold 37,311 Celgene Corp shares in Q4 2019, an estimated $3.71M.
Wealthfront Advisers first reported a position in Celgene Corp in Q4 2018 and held it in 4 quarters.
Wealthfront Advisers's Celgene Corp position peaked at $3.71M in Q3 2019.
3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Wealthfront Advisers's 13F filing for Q4 2019, filed 21 Jan 2020.